Federal Appeals Court Rejects Hearing On Cox-2 Patent

Law360, New York (July 6, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has denied the University of Rochester’s request for a hearing by the court’s full panel on the validity of a patent for cox-2 inhibitors such as Pfizer’s $3 billion Celebrex drug.

University of Rochester scientists claim they discovered the gene that produces the cox-2 enzyme and described the role it plays in producing inflammation and pain. Cox-2 inhibitors are drugs that can relieve pain and inflammation without causing cramps and bleeding.

The university applied for the patent...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.